238 related articles for article (PubMed ID: 30556860)
1. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
Lu K; Dong JL; Fan WJ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
[TBL] [Abstract][Full Text] [Related]
2. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
3. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
4. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
7. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
8. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
9. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
10. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
11. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
Tao L; Zhu Y; Gu Y; Zheng J; Yang J
Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
[TBL] [Abstract][Full Text] [Related]
12. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
13. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
[TBL] [Abstract][Full Text] [Related]
15. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
16. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Han M; Xu W
Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375
[TBL] [Abstract][Full Text] [Related]
17. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
18. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
[TBL] [Abstract][Full Text] [Related]
19. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
